At Merck, we share your passion for developing novel, breakthrough products. You've discovered something significant, and we are inspired by your innovation. Our philosophy is to bring medical excellence to patients through
first-in-class/best-in-class products for unmet medical needs.
We are seeking partners for:
-
New Chemical Entities (NCEs) and New Molecular Entities (NMEs) as product candidates for development.
-
Basic research collaborations
-
Technologies that will enhance the productivity of our research laboratories
What we are looking for in a licensing candidate:
We welcome viable compounds in development, targets with proof of concept, molecules with a defined mechanism of action (or a testable hypothesis), and technologies that provide a competitive advantage. We are most interested in compounds that have large market potential for unmet medical needs, and that can be developed rapidly. An attractive compound would have selectivity, potency, a demonstrated mechanism of action, preliminary toxicology data, oral availability, and a good half-life for once-daily administration. We also look for strong intellectual property protection on the target and the molecule.
What we are looking for in a proposal:
When contacting us about your discovery, we ask that you provide a clear, concise, nonconfidential data package for review, and that you highlight the advantages of your discovery and provide a perspective on its value within the competitive landscape. In preparing the package, it may be helpful to consider that our review process is centralized and includes review by the appropriate experts from basic biology, chemistry, preclinical, clinical, marketing, and patent.
We look forward to hearing from you about your discovery. Together we can translate cutting-edge science into breakthrough medicines.
|
PDF*)
Printer Friendly Page
